Literature DB >> 29452546

Appropriate Chemotherapy Dosing for Obese Adult Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline.

Jennifer J Griggs1, Pamela B Mangu1, Sarah Temin1, Gary H Lyman1.   

Abstract

Entities:  

Year:  2012        PMID： 29452546      PMCID： PMC3396831          DOI： 10.1200/JOP.2012.000623

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN： 1554-7477            Impact factor:   3.840


× No keyword cloud information.
  1 in total

Review 1.  Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline.

Authors:  Jennifer J Griggs; Pamela B Mangu; Holly Anderson; Edward P Balaban; James J Dignam; William M Hryniuk; Vicki A Morrison; T May Pini; Carolyn D Runowicz; Gary L Rosner; Michelle Shayne; Alex Sparreboom; Lara E Sucheston; Gary H Lyman
Journal:  J Clin Oncol       Date:  2012-04-02       Impact factor: 44.544
  1 in total
  8 in total

1.  Incidence of trastuzumab-induced cardiotoxicity and impact of body mass index in patients with breast cancer: Results from a Saudi tertiary cancer center.

Authors:  Khalid Al-Saleh; Ahmed Abdel-Warith; Mohammed Alghamdi; Abdurrahman Aldiab; Arwa Ali; Eyad Fawzi Alsaeed; Waleed Nabeel Abozeed; Nashwa Abdel-Aziz
Journal:  Mol Clin Oncol       Date:  2022-02-08

2.  The evolution of body composition in oncology-epidemiology, clinical trials, and the future of patient care: facts and numbers.

Authors:  Justin C Brown; Elizabeth M Cespedes Feliciano; Bette J Caan
Journal:  J Cachexia Sarcopenia Muscle       Date:  2019-01-13       Impact factor: 12.910

3.  Symptom Experience, Management, and Outcomes According to Race and Social Determinants Including Genomics, Epigenomics, and Metabolomics (SEMOARS + GEM): an Explanatory Model for Breast Cancer Treatment Disparity.

Authors:  Maura K McCall; Mary Connolly; Bethany Nugent; Yvette P Conley; Catherine M Bender; Margaret Q Rosenzweig
Journal:  J Cancer Educ       Date:  2020-06       Impact factor: 2.037

Review 4.  The ambiguous role of obesity in oncology by promoting cancer but boosting antitumor immunotherapy.

Authors:  José Antônio Fagundes Assumpção; Gabriel Pasquarelli-do-Nascimento; Mariana Saldanha Viegas Duarte; Martín Hernan Bonamino; Kelly Grace Magalhães
Journal:  J Biomed Sci       Date:  2022-02-14       Impact factor: 8.410

5.  Impact of African ancestry on the relationship between body mass index and survival in an early-stage breast cancer trial (ECOG-ACRIN E5103).

Authors:  Tarah J Ballinger; Guanglong Jiang; Fei Shen; Kathy D Miller; George W Sledge; Bryan P Schneider
Journal:  Cancer       Date:  2022-03-14       Impact factor: 6.921

Review 6.  Metabolic risk factors of ovarian cancer: a review.

Authors:  Neda Khanlarkhani; Elham Azizi; Fardin Amidi; Mahshad Khodarahmian; Ensieh Salehi; Azar Pazhohan; Bagher Farhood; Keywan Mortezae; Nasser Hashemi Goradel; Maryam Shabani Nashtaei
Journal:  JBRA Assist Reprod       Date:  2022-04-17

7.  The influence of body mass index on the tolerability and effectiveness of full-weight-based paclitaxel chemotherapy in women with early-stage breast cancer.

Authors:  Lishi Lin; Marcel Soesan; Dorieke E M van Balen; Jos H Beijnen; Alwin D R Huitema
Journal:  Breast Cancer Res Treat       Date:  2022-08-16       Impact factor: 4.624

8.  Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical Trials.

Authors:  Joseph M Unger; Riha Vaidya; Kathy S Albain; Michael LeBlanc; Lori M Minasian; Carolyn C Gotay; N Lynn Henry; Michael J Fisch; Shing M Lee; Charles D Blanke; Dawn L Hershman
Journal:  J Clin Oncol       Date:  2022-02-04       Impact factor: 50.717
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.